Antiviral Therapy in Hepatitis B Virus-Associated Liver Cirrhosis

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians2014 · 210 citations
2. 2Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B†,‡2010 · 995 citations
3. 3Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study2011 · 187 citations
4. 4Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis2012 · 186 citations